₹ 694.5 Cr
2.37%
S&P BSE Healthcare TRI
INF209KB1N91
1000.0
1000.0
1000
Dhaval Shah, Dhaval Joshi
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | 55.25 | 13.98 | - |
S&P BSE Healthcare TRI | 54.47 | 14.49 | 22.72 |
Equity
Debt
Others
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 14.84 |
Cipla Ltd. | 7.83 |
Torrent Pharmaceuticals Ltd. | 7.41 |
Apollo Hospitals Enterprise Ltd. | 6.33 |
Others | 4.86 |
Fortis Healthcare Ltd. | 4.59 |
Zydus Lifesciences Ltd. | 4.25 |
Ajanta Pharma Ltd. | 4.16 |
Aurobindo Pharma Ltd. | 4.01 |
Lupin Ltd. | 3.89 |
Sector | Holdings (%) |
---|---|
Healthcare | 91.77 |
Others | 4.72 |
Insurance | 2.01 |
Services | 1.05 |
Chemicals | 0.45 |
Scheme Name | 5Y (%) |
---|---|
ABSL Pharma and Healthcare Reg Gr | 0.0 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 26.23 |
Tata India Pharma & Healthcare Reg Gr | 24.12 |
Nippon India Pharma Fund Gr Gr | 25.26 |
SBI HEALTHCARE Opportunities Reg Gr | 25.56 |
DSP Healthcare Reg Gr | 27.15 |
UTI Healthcare Reg Gr | 23.08 |
Mirae Asset Healthcare Reg Gr | 25.59 |
LIC MF Healthcare Fund Reg Gr | 20.02 |
ITI Pharma and Healthcare Fund Reg Gr | 0.0 |